Drug
Faldaprevir sodium clinical trials
Also written BI 201335 NA.
A product of Faldaprevir; its studies count on that page too.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
6 studies that test it; most in 2012 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Deleobuvir sodium (2) · Deleobuvir (2) · Ribavirin (1) · Midazolam (1) · Tolbutamide (1)
Studies
Open first, then newest update. How each study uses faldaprevir sodium is read from its arms, and is right about nine times in ten.
Testing it · 6
- This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis CCompletedPhase 2Boehringer IngelheimNCT01528735Written as BI 201335 NA
- Bioequivalence Trial of 2 Dose Strengths of BI 201335 NA Soft Gelatine CapsulesCompletedPhase 1Boehringer IngelheimNCT01704846Written as BI 201335 NA 120 mg capsule
- Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 201335 NA in Healthy Male SubjectsCompletedPhase 1Boehringer IngelheimNCT02182362Written as BI 201335 NA
- Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of BI 201335 NA and Bioavailability in Healthy Male SubjectsCompletedPhase 1Boehringer IngelheimNCT02182323Written as BI 201335 NA
- Effects of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail in Healthy VolunteersCompletedPhase 1Boehringer IngelheimNCT02182336Written as BI 201335 NA
- Multiple Doses of BI 207127 NA, BI 201335 NA Followed by the Combination of BI 207127 NA and BI 201335 NA in Healthy Male VolunteersTerminatedPhase 1Boehringer IngelheimNCT02182401Written as BI 201335 NA
Given in every arm · 2 — faldaprevir sodium is usual care beside what is tested
- Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)CompletedPhase 2Boehringer IngelheimNCT00774397Written as BI 201335 NA 240 mg QD / LI
- Effect of BI 201335 Mediated UGT1A1 (Uridine-diphosphate-glucuronosyltransferases) Inhibition in Healthy VolunteersCompletedPhase 1Boehringer IngelheimNCT02182375Written as BI 201335 NA
Codes
What other systems call faldaprevir sodium · ClinicalTrials.gg INT014277
- UNII (FDA) 1494Q15E7ZFALDAPREVIR SODIUMConfirmed FDA, Wikidata
- Wikidata Q27251616faldaprevir sodiumConfirmed FDA, Wikidata
- NCI Thesaurus C166460Faldaprevir SodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 1494Q15E7Z | FALDAPREVIR SODIUM | Confirmed FDA, Wikidata |
| Wikidata | Q27251616 | faldaprevir sodium | Confirmed FDA, Wikidata |
| NCI Thesaurus | C166460 | Faldaprevir Sodium | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.